Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M Sáez-Torres de Vicente"'
4CPS-340 Profile of patients with abusive consumption of quick release fentanyl in a healthcare area
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance In recent years, the prescription of immediate release fentanyl (whose indication is breakthrough pain of oncological origin treated with a basic opioid analgesic) has increased, in many cases for off-label indications, and
Autor:
J Hernandez Parada, G Ruiz Arca, Á Perea Pérez, L Garcia Martinez, T Lopez Viñau Lopez, M Sáez-Torres de Vicente
Publikováno v:
Section 6: Education and research.
Background and importance Most antimicrobial stewardship programmes (ASP) use a before-and-after research design, which has a high risk of bias. Efforts to enhance the conduct of these quasi-experimental studies are urgently needed to more rigorously
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Frias Casas, A Rivero Juarez, MT Brieva Herrero, M Sáez-Torres de Vicente, P López López, I Reyes Torres
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The scale-up of HCV treatment for HIV/HCV coinfected individuals is occurring, the majority with a history of injecting drug use. Purpose We assess the implications for achieving the World Health Organisation HCV incidence elimination targ
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The new direct antiviral agents (DAAs) have substantially modified the situation of hepatitis C virus (HCV) infection patients, achieving very high viral response rates.1 However, in certain patients, treatment with DAAs fails. Purpose Our
Autor:
M Sáez-Torres de Vicente, PJ Gómez Arias, J Hernandez Parada, B. Isla Tejera, J. Ruano Ruiz, F Gómez García
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Deficiency in interleukin-1 (IL-1) receptor (IL-R) antagonist (DIRA) is a rare genetic autoinflammatory disorder resulting from autsomal recessive mutations in the IL1RN gene. The use of IL-1 antagonists may prove to be a valid therapeutic
Autor:
F J Gómez Garcia, J. Ruano Ruiz, PJ Gómez Arias, J Hernandez Parada, B. Isla Tejera, M Sáez-Torres de Vicente
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Alterations in the interleukin (IL)−1 pathway have been shown to be involved in the pathogenesis of some auto-inflammatory diseases. Deficiency of the IL-36R antagonist (DITRA) is a recently described rare hereditary disease in which IL-
Autor:
IReyes Torres, J Hernandez Parada, TLopez Viñau Lopez, López Malo de Molina, J López-Santamaria Donoso, M Sáez-Torres de Vicente
Publikováno v:
Eur J Hosp Pharm
Background Dolutegravir (DTG), a second-generation integrase strand transfer inhibitor (INSTI), is currently among the most commonly used antiretroviral agents. Recent reports have raised concerns about their safety, especially with regard to neurops
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3830be9916fa7c9e8afaf93f4c07038f
https://europepmc.org/articles/PMC7535272/
https://europepmc.org/articles/PMC7535272/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.